dk
ll
i
|
Table 4,
Po
|
|
WBC
(x 103)
Postexposure day
|
i
|
<5
3
9.0
7
4.9
10
6.6
12
*5.9
15
5.9
18
6.7
22
7.0
26
5.7
30
7.6
33
6.5
39
5.7
43
5.2
47
5.9
51
6.7
56
7.0
63
7.7
70
7.6
74
6-Mo. survey
8.5
1-Yr. survey
10.1
2-Yr. survey
11.8
Majuro controls
13.2
Rita controls, 6 mo. 10.7
Rita controls, 1 yr.
Rita controls, 2 yr.
14.0
Rongelap group and control mean blood counts by day and by age.
Neutrophiles
(x 103)
Platelets
(x 10%)
Lymphocytes
(x 103)
>5
<5
>5
<5
>5
Male
<10
8.2
6.2
7.1
6.3
6.5
7.2
7.4
6.1
7.8
6.2
5.5
5.2
5.8
5.6
6.0
6.0
6.5
6.6
8.2
8.6
9.7
7.6
8.9
o.4
3.5
3.5
3.2
3.4
4.3
3.0
4.0
3.1
3.0
2.0
2.6
2.6
3.5
3.9
3.8
4.6
4.7
5.9
4.8
5.4
7.0
4.7
4.5
3.9
4.1
4.7
5.0
3.9
5.3
3.8
3.3
2.6
3.3
3.5
3.5
3.6
4.0
4,2
4.8
4.8
4.8
5.2
4.4
1.8
2.6
2.1
2.4
2.4
2.6
2.3
3.2
3.2
2.6
2.9
3.1
3.4
3.7
3.7
3.3
3.6
4.6
4.7
7.4
4.7
5.6
2.2
2.1
1.7
1.9
2.1
2.1
1.8
2.1
2.0
2.0
2.3
2.4
2.1
2.4
2.3
2.2
2.2
2.8
3.1
4,1
3.7
3.6
28.2
27.1
21.8
16.8
13.2
14.1
17.9
25.5
26.8
24.6
22.1
23.1
26.2
24.4
26.6
30.0
41.2
35.0
37.5
35.5
Monocytes
(x 104)
Eosinophiles
(x 102)
Male
>10
Female
allages
Total
group
<5
35
<5
>5
22.7
21.3
19.1
14.6
12.9
12.3
16.6
22.0
20.9
20.6
17.5
18.2
21.7
20.3
19.5
21.4
25.8
27.3
24.5
24.2
24.9
21.7
21.8
15.2
10.9
11.8
15.1
22.4
23.2
23.9
21.2
20.2
24.7
23.2
27.6
25.5
36.5
30.9
29.4*®
31.2
24.8
22.5
21.0
15.3
11.9
12.3
16.0
22.8
23.2
23.1
20.3
20.1
24.1
22.6
24.9
24.7
33.4
30.4
27.6
29.5
0.8
2.9
4.2
3.0
2.7
1.9
1.9)
1.5
17
0.9
1.1
1.0
2.5
17
0.5
-<
1.4
O.7
2.7
2.0
1.9
1.4
0.3
1.7
5.4
2.3
1.7
2.0
1.6
0.9
61.6
«0.9
1.
1.0
1.6
1.2
0.9
1}
1.3
1.5
2.0
1.7
1.5
O.1
1.6
1.9
1.)
3.5
2.3
1.8
3.4
2.6
0.5
1.4
1,1
0.8
0,3
3.4
2.5
"6.7
9.6
9.5
4.2
12.8
0.7
1.6
1.9
1.3
1.6
1.8
1.3
2.2
2.2
1.0
0.8
0.5
0.7
26
1.9
1.6
2.8
5.3
4.7
4.8
6.6
“Excluding pregnancy.
Table 5,
WBC
(x 103)
Ailingnae group and control mean blood counts by day and by age.
Neutrophiles
(x 103)
Postexposure day
<5
>5
<5
3
7
10
12
15
18
22
26
30
33
39
43
47
51
54
6-Mo. survey
1-Yr. survey
2-Yr. survey
Majuro controls
Rita controls, 2yr.
6.0
5.5
6.3
6.3
7.1
6.8
8.9
8.4
9.6
7.7
7.5
6.9
7.3
8.4
4.6
7.7
11.1
110
13.2
14.1
7.0
6.8
7.3
7.6
7.0
7.8
8.7
7.0
8.6
748
6.2
6.5
6.7
6.3
6.3
6.5
7.8
9.1
9.7
8.9
3.0
4.2
1.8
2.3
2.9
5.3
4.8
5.3
3.3
2.9
2.7
3.5
3.8
2.8
4.8
4.2
4.9
4.8
7.0
>5
5.0
4.2
4.7
4.5
5.0
5.4
4.4
6.2
5.2
4.2
3.6
3.8
3.6
3.5
3.9
4.7
5.1
4.8
4.4
Platelets
Lymphocytes
(x 103)
(x 104)
<5
>5
Male
<l0
2.8
1.9
3.1
4.2
3.5
2.7
3.2
3.7
3.5
4.7
3.9
3.4
4.0
3.2
2.7
6.5
4.8
7.4
5.6
2.2
2.2
2.2
2.2
2.4
2.9
2.2
2.0
2.2
1.9
2.7
2.7
2.2
2.5
2.2
5.6
3.2
4.1
3.6
22.5
29.0
27.5
23.5
20.0
19.5
24.0
26.5
28.0
27.0
32.0
37.0
25.2
38.7
51.2
41.2
35.5
Male
>10
22.6
20.2
21.7
17.0
13.8
12.8
15.8
20.8
19.6
20.0
18.2
19.8
19.2
21.4
17.4
25.8
24.2
Female
all ages
20.9
24.6
24.9
22.9
17.4
18.2
22.7
27.0
25.3
26.1
25.0
23.8
23.9
28.3
26.4
36.5
31.2
Monocytes
Total
group
21.5
23.9
24,3
21.3
16.7
16.8
17.6
25.2
24.0
24.5
23.9
24,2
22.7
27.5
26,7
33.4
29.5
{x 102)
<5
0.8
3.8
3.4
3.7
2.30
1.5
2.3.
1.9
2.8
Li
0.6
2.2
2.7
1.5
1.1
1.0
3.6
2.0
1.4
Eosinophiles
(x 102)
>5
<5
>5
1.6
2.1
5.8
2.6
1.5
2.4
2.4
1.9
2.2
1.7
1.4
1.9
2.8
1.9
1.4
1.1
1.4
2.0
1.5
05
2.6
4.4
2.3
3.2
5.8
0.6
4.1
6.0
2.7
2.8
1.5
2.2
1.8
1.5
1.7
9.6
9.5
12.8
0.4
1.6
2.6
1.4
2.3
2.4
1.6
2.0
1.9
1.6
0.6
0.7
1.0
0.8
2.2
2.2
6.4
4.7
6.6
|